Larvol Delta - Effects-of-Limited-versus-Standard-Dose-Romosozumab-followed-by-Denosumab-on-Peripheral-Bone-Density-and-Microarchitecture-The-LIDAHRpQCT-Extension-study

ASP2138 - Astellas

https://www.prnewswire.com/news-releases/astellas-doses-first-patient-in-phase-3-study-of-asp2138-in-cldn18-2-postive-and-her2-negative-locally-advanced-unresectable-or-metastatic-gastric-or-gastroesophageal-junction-gej-adenocarcinoma-302858691.html

Aug 24, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next